Report Categories
View AllRecent Articles
View All
Anik Stock Analysis Anika Therapeutics Inc. Gains 3.31 Percent Daily Trades At 14.98 Dollar 20260401 1
CIOs Turn to Vibe Coding as Business Users Build Custom Apps
Sebi Bars Seven Entities for Stock Manipulation via Social Media Freezes 20 Crore Gains
Former London Capital Finance Boss Jailed for Breaching Restraining Order by Selling Hot Tub and Luxury Items
Broadridge Financial Stock Outlook Analyst Sentiment Remains Cautiously Optimistic
Trump Delays AI Executive Order Citing Concerns Over Potential Constraints
Japan Inc Maintains Cautious Stance on Philippine Business as President Marcos Visits Tokyo
Afya Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower
TechPrecision Corporation TPCS Q1 2026 Earnings Narrowing Losses Amid Strategic Restructuring
HBIO Q1 2026 Earnings Loss Narrower Than Expected on Cost Controls
KMPB Q1 2026 Earnings Significant Earnings Miss Raises Concerns for FixedRate Reset Debentures
SCVL Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Retail Footwear Market
Commercial Vehicle Group Inc CVGI Rallies as Shares Test Key Resistance Level
SL Green Realty Corp SLG Gains 169 as Office REIT Shows Resilience
FIS Edges Lower Amid Consolidation as Stock Hovers Near Support Levels
Workhorse Group WKHS Rebounds to 34 Bullish Momentum Tests Key Resistance
Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted
External Links
DeepSeek Slashes Flagship AI Model Price by 75 in Permanent Reduction
RUM Q1 2026 Earnings EPS Misses Estimates Stock Gains as Platform Expands
Axe Compute Inc AGPU Rockets 2959 Higher Testing Key Resistance
Hooker Furnishings HOFT Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand
OCCI Q1 2026 Earnings Massive EPS Miss Sends Stock Down
IQV Q1 2026 Earnings EPS Beats Expectations as Stock Gains 22
PKE Q1 2026 Earnings EPS of 015 Reported Amidst Quiet Quarter
BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development
SRRK Q1 2026 Earnings Narrowed EPS Miss and Steady Pipeline Progress Amid No Revenue
TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher